Le Lézard
Classified in: Science and technology, Business
Subjects: ERN, ERP

Life360 reports Q2 and Half Year 2022 results


SAN FRANCISCO, Aug. 15, 2022 /PRNewswire/ -- San Francisco-based Life360, Inc. (Life360 or the Company) (ASX: 360) today reported financial results for the three months and six months ended 30 June 2022 (unaudited).

Life360 Chief Executive Officer Chris Hulls said: "Life360's significant business momentum continued in the June 2022 quarter, with net subscriber additions of 111,000, the second highest ever quarterly growth and Monthly Active Users continuing to reach new heights. Annualised Monthly Revenue (excluding hardware) of $174 million is a 65% year-on-year uplift.

"We are seeing resilience from our subscribers and users in the face of more challenging global macroeconomic circumstances, with our usual 'back-to-school' seasonal uplift underway. While we continue to monitor global macroeconomic conditions, in fact we continue to see strong growth in our user and subscriber performance, and maintain confidence in a very promising outlook. With the increasing value of our Membership offering, we are currently market testing higher price points. Although early, the results demonstrate the value of our services and significant pricing power. We are exploring price increases as part of our overall strategy of expanding Membership with hardware devices.

"Our unified platform has been established to launch our bundled hardware Membership offering with the initial rollout matching our very encouraging earlier trial results which delivered a 35% uplift in subscriptions versus the control group. 

"As expected, CY22 H1 was a peak period for investment as we rapidly integrated core Life360 with the Tile and Jiobit acquisitions. We expect significantly lower operating losses and cash burn in H2 as we benefit from the early results from the bundled Membership offer, and Tile's usual strong Q4 seasonality. In addition, we expect cost efficiencies arising from the integration, with ~$11m of annualised costs savings expected in H2. Our confidence in a trajectory to Adjusted EBITDA profitability and positive cash flow for CY24 is underpinned by the considerable conversion, upsell and retention upside from bundled Membership, our leaner organisational structure, and outlook for lower subscriber commissions based on out of app purchases."

Key Performance Indicators1







 

(in millions, except ARPPC,ARPS,ASP)

Q2 2022

Q1 2022

Q2 2021

% ch YoY

% ch QoQ

Life360 Core






Monthly Active Users (MAU) - Total

42.0

38.3

32.4

29 %

10 %

    US

27.0

25.1

20.4

33 %

8 %

    International

14.9

13.2

12.1

24 %

13 %

    Australia

1.1

1.0

0.8

34 %

8 %

Paying Circles - Total

1.42

1.31

1.01

41 %

8 %

    US - Total

1.14

1.06

0.82

39 %

7 %

    International

0.28

0.25

0.19

48 %

13 %

Average Revenue Per Paying Circle (ARPPC)

$89.34

$87.66

$79.95

12 %

2 %

Life360 Consolidated (Proforma for 2021)






Subscriptions

1.97

1.85

1.46

35 %

7 %

Average Revenue per Subscription (ARPS)

$75.45

$73.88

$66.82

13 %

2 %

Net hardware units shipped

0.47

0.70

1.02

-54 %

-32 %

Average Sale Price (ASP)

$14.48

$15.08

$15.70

-8 %

-4 %














1

Numbers may not add or recalculate due to rounding

Monthly Active Users - US v International

Paying Circles - Membership Plans

Operating Results2

Revenue

($ millions) (unaudited)

Q2 2022

Q2 2021

H1 2022

H1 2021

Revenue





  Subscription (direct)

36.0

19.2

69.1

36.4

  Hardware

6.8

-

16.5

-

  Other (indirect)

6.0

5.8

14.3

11.6

Total

48.8

25.0

99.8

48.0

Annualised Monthly Revenue - June

174.4

105.9

174.4

105.9

Gross Profit

(unaudited)

Q2 2022

Q2 2021

H1 2022

H1 2021

Gross Profit ($M)

29.3

20.2

64.4

38.8

Gross Margin

60.4 %

80.8 %

64.7 %

80.8 %

2

Numbers may not add or recalculate due to rounding

 

Operating expenses

($ millions) (unaudited)

Q2 2022

Q2 2021

H1 2022

H1 2021

Research and Development

27.0

12.0

52.8

22.7

Sales and Marketing

22.9

10.6

46.1

18.8

    Paid Acquisition & TV

7.0

2.5

13.6

4.7

    Commissions

6.4

5.1

14.7

9.4

    Other sales and marketing

9.5

3.0

17.8

4.7

General and administrative

12.8

4.5

26.1

7.9

Total operating expenses

62.8

27.1

125.0

49.4

EBITDA and Adjusted EBITDA3

($ millions) (unaudited)

Q2 2022

Q2 2021

H1 2022

H1 2021

Net Loss

(33.0)

(6.8)

(58.2)

(10.7)

EBITDA

(31.2)

(6.7)

(56.1)

(10.4)

Non-GAAP Adjustments

12.4

3.4

23.8

5.6

Adjusted EBITDA

(18.7)

(3.3)

(32.3)

(4.8)

3

EBITDA and Adjusted EBITDA are non-GAAP measures. For definitions of EBITDA and Adjusted EBITDA and the use of these non-GAAP measures, as well as a reconciliation of Net Loss to EBITDA and Adjusted EBITDA see pages 6-8.

 

Balance sheet and Cash flow4

($ millions) (unaudited)

Q2 2022

Q2 2021

H1 2022

H1 2021

Net cash used in operating activities

(16.9)

(1.9)

(38.5)

(4.9)

Net cash (used in) provided by investing activities

(1.4)

(2.5)

(113.8)

(2.5)

Net cash provided by financing activities

(0.6)

1.6

0.3

1.6

Net (decrease) increase in cash and cash equivalents

(18.9)

(2.8)

(152.0)

(5.9)

Cash, cash equivalents and restricted cash at period end

79.3

50.8

79.3

50.8

 

4

Numbers may not add or recalculate due to rounding

Earnings Guidance5

As previously indicated,  CY22 H1 was a period of significant investment. Life360 expects to start realizing the benefits of integration in H2, as we launch the bundled Membership offering, and see an uplift in hardware in the seasonally higher holiday period in Q4.  As a result, CY22 H2 is expected to see considerably lower cash burn, and a much lower Adjusted EBITDA6 loss.

For CY22 Life360 expects to deliver:

We have upgraded our guidance for Life360 subscription revenue growth, and narrowed the range for Consolidated Revenue and Adjusted EBITDA.

Life360 expects to finish CY22 with cash and cash equivalents of approximately $65 million.

We expect Life360 to be on a trajectory to consistently positive Adjusted EBITDA and Operating Cash Flow by late CY23, such that we record positive Adjusted EBITDA and Operating Cash Flow for CY24. This trajectory could be further assisted by the positive impact of potential future price changes.

5

In regards to forward looking non-GAAP guidance, we are not able to reconcile the forward-looking non-GAAP Adjusted EBITDA measure to the closest corresponding GAAP measure without unreasonable efforts because we are unable to predict the ultimate outcome of certain significant items. These items include, but are not limited to, litigation costs, convertible notes and derivative liability fair value adjustments, and gain on revaluation of contingent consideration.

6

Adjusted EBITDA was previously referred to as Underlying EBITDA. For definitions of EBITDA and Adjusted EBITDA and the use of these non-GAAP measures, as well as a reconciliation of Net Loss to EBITDA and Adjusted EBITDA see pages 6-8.

Investor Conference Call

A conference call will be held today at 9.30am AEST, Tuesday 16 August 2022 (Monday 15 August 2022 US PT at 4.30pm). The call will be held as a Zoom audio webinar.

Participants wishing to ask a question should register and join via their browser here
Participants joining via telephone will be in a listen only mode.
Dial in details
Australia :  +61 2 8015 6011
US : +1 669 900 6833
Other countries : details
Meeting ID : 946 2708 7392

A replay will be available after the call at https://investors.life360.com

Authorisation

Chris Hulls, Director, Co-Founder and Chief Executive Officer of Life360 authorised this announcement being given to ASX.

About Life360

Life360 operates a platform for today's busy families, bringing them closer together by helping them better know, communicate with and protect the people they care about most. The Company's core offering, the Life360 mobile app, is a market leading app for families, with features that range from communications to driving safety and location sharing. Life360 is based in San Francisco and had 42 million monthly active users (MAU) as at June 2022, located in more than 150 countries.

Contacts


For Australian investor enquiries:  

For Australian media enquiries:

Jolanta Masojada, +61 417 261 367      

Giles Rafferty, +61 481 467 903

jmasojada@life360.com                    

grafferty@firstadvisers.com.au



For U.S. investors       

For US media enquiries:                     

investors@life360.com

press@life360.com     

            

Life360's CDIs are issued in reliance on the exemption from registration contained in Regulation S of the US Securities Act of 1933 (Securities Act) for offers of securities which are made outside the US. Accordingly, the CDIs, have not been, and will not be, registered under the Securities Act or the laws of any state or other jurisdiction in the US. As a result of relying on the Regulation S exemption, the CDIs are 'restricted securities' under Rule 144 of the Securities Act. This means that you are unable to sell the CDIs into the US or to a US person who is not a QIB for the foreseeable future except in very limited circumstances until after the end of the restricted period, unless the re-sale of the CDIs is registered under the Securities Act or an exemption is available. To enforce the above transfer restrictions, all CDIs issued bear a FOR Financial Product designation on the ASX. This designation restricts any CDIs from being sold on ASX to US persons excluding QIBs. However, you are still able to freely transfer your CDIs on ASX to any person other than a US person who is not a QIB. In addition, hedging transactions with regard to the CDIs may only be conducted in accordance with the Securities Act.

Future performance and forward-looking statements

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Life360 intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can be about future events, including statements regarding Life360's intentions, objectives, plans, expectations, assumptions and beliefs about future events, including Life360's expectations with respect to the financial and operating performance of its business, its capital position, future growth,and its integration of Tile and Jiobit. The words "anticipate, "believe", "expect", "project", "predict", "will", "forecast", "estimate", "likely", "intend", "outlook", "should", "could", "may", "target", "plan" and other similar expressions can generally be used to identify forward-looking statements. Indications of, and guidance or outlook on, future earnings or financial position or performance are also forward-looking statements. Investors and prospective investors are cautioned not to place undue reliance on these forward-looking statements as they involve inherent risk and uncertainty (both general and specific) and should note that they are provided as a general guide only. There is a risk that such predictions, forecasts, projections and other forward-looking statements will not be achieved. Subject to any continuing obligations under applicable law, Life360 does not undertake any obligation to publicly release the result of any revisions to these forward-looking statements to reflect events or circumstances after the date of this announcement, to reflect any change in expectations in relation to any forward-looking statements or any change in events, conditions or circumstances on which any such statements are based. While due care has been used in the preparation of forecast information, actual results may vary in a materially positive or negative manner. Forward-looking statements are provided as a general guide only and should not be relied on as an indication or guarantee of future performance. They are subject to known and unknown risks, uncertainty, assumptions and contingencies, many of which are outside Life360's control, and are based on estimates and assumptions that are subject to change and may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include risks described in the Company's ASX filings, Form 10 Registration Statement and subsequent reports filed with the Securities and Exchange Commission. To the maximum extent permitted by law, responsibility for the accuracy or completeness of any forward-looking statements whether as a result of new information, future events or results or otherwise is disclaimed. This announcement should not be relied upon as a recommendation or forecast by Life360. Past performance information given in this document is given for illustrative purposes only and is not necessarily a guide to future performance and no representation or warranty is made by any person as to the likelihood of achievement or reasonableness of any forward-looking statements, forecast financial information, future share price performance or any underlying assumptions. Nothing contained in this document nor any information made available to you is, or shall be relied upon as, a promise, representation, warranty or guarantee as to the past, present or the future performance of Life360.

Supplemental Business Metrics7

 

(in millions, except ARPPC,ARPS,ASP)

Q1 2021

Q2 2021

Q3 2021

Q4 2021

Q1 2022

Q2 2022

Life360 Core







Monthly Active Users (MAU) - Total

28.1

32.4

33.8

35.5

38.3

42.0

    US

18.1

20.4

22.2

23.7

25.1

27.0

    International

10.0

12.1

11.6

11.8

13.2

14.9

    Australia

0.7

0.8

0.8

1.0

1.0

1.1

Paying Circles - Total

0.92

1.01

1.12

1.24

1.31

1.42

    US - Total

0.75

0.82

0.91

1.01

1.06

1.14

         US ? Membership subscribers

0.23

0.33

0.45

0.56

0.64

0.73

    International

0.17

0.19

0.21

0.23

0.25

0.28

Average Revenue Per Paying Circle (ARPPC)

$75.92

$79.95

$85.78

$88.69

$87.66

$89.34








Life360 Consolidated (Proforma for 2021)







Subscriptions

1.34

1.46

1.60

1.75

1.85

1.97

Average Revenue per Subscription (ARPS)

$63.70

$66.82

$71.65

$74.04

$73.88

$75.45

Net hardware units shipped

0.88

1.02

1.02

3.33

0.70

0.47

Average Sale Price (ASP)

$15.68

$15.70

$13.58

$15.12

$15.08

$14.48













7

Numbers may not add or recalculate due to rounding

 

Non-GAAP Financial Measures

We collect and analyze operating and financial data to evaluate the health of our business, allocate our resources and assess our performance.

EBITDA and Adjusted EBITDA

In addition to total revenue, net loss and other results under GAAP, we utilize non-GAAP calculations of earnings before interest, taxes, depreciation and amortization ("EBITDA") and adjusted earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA"). EBITDA is defined as Net loss, excluding (i) convertible notes and derivative liability fair value adjustments, (ii) provision (benefit) for income taxes, (iii) depreciation and amortization, (iv) other income (expense). Adjusted EBITDA is defined as Net Loss, excluding (i) convertible notes and derivative liability fair value adjustments, (ii) provision (benefit) for income taxes, (iii) depreciation and amortization, (iv) other income (expense), (v) stock-based compensation, (vi) Form 10 transaction costs, (vii) acquisition and integration costs, and (viii) gain on revaluation of contingent consideration.

The above items are excluded from Adjusted EBITDA because these items are non-cash in nature, or because the amount and timing of these items are unpredictable, are not driven by core results of operations and render comparisons with prior periods and competitors less meaningful. We believe EBITDA and Adjusted EBITDA provide useful information to investors and others in understanding and evaluating our results of operations, as well as providing useful measures for period-to-period comparisons of our business performance. Moreover, we have included EBITDA and Adjusted EBITDA in this Quarterly Report on Form 10-Q because they are key measurements used by our management team internally to make operating decisions, including those related to operating expenses, evaluate performance, and perform strategic planning and annual budgeting. However, these non-GAAP financial measures are presented for supplemental informational purposes only, should not be considered a substitute for or superior to financial information presented in accordance with GAAP, and may be different from similarly titled non-GAAP financial measures used by other companies. As such, you should consider these non-GAAP financial measures in addition to other financial performance measures presented in accordance with GAAP, including various cash flow metrics, net loss and our other GAAP results.

The following table presents a reconciliation of Net Loss, the most directly comparable GAAP measure, to EBITDA and Adjusted EBITDA.


Three Months Ended June 30,


Six Months Ended June 30,


2022


2021


2022


2021


(in thousands)


(in thousands)

EBITDA








Net Loss

$            (32,985)


$              (6,804)


$            (58,207)


$            (10,656)

Add (deduct):








Convertible notes fair value adjustment

(532)


?


(2,107)


?

Derivative liability fair value adjustment (1)

(415)


?


(1,328)


?

Provision (benefit) for income taxes

(47)


?


11


?

Depreciation and amortization (2)

2,301


112


4,502


224

Other (income) expense, net

511


(3)


1,056


(8)

EBITDA

$            (31,167)


$              (6,695)


$            (56,073)


$            (10,440)

Stock-based compensation

10,429


2,941


16,524


5,140

Form 10 transaction costs

2,138


?


2,138


?

Acquisition and integration costs

1,136


499


10,394


499

Gain on revaluation of contingent consideration

(1,279)


?


(5,279)


?

Adjusted EBITDA

$            (18,743)


$              (3,255)


$            (32,296)


$              (4,801)

__________________

(1)

To reflect the change in value of the derivative liability associated with the July 2021 Convertible Notes

(2)

Includes depreciation on fixed assets and amortization of acquired intangible assets.

 

Adjusted loss from ordinary activities after tax

Adjusted loss from ordinary activities after tax is defined as Net Loss, excluding (i) stock-based compensation, (ii) Form 10 transaction costs, (iii) acquisition and integration costs, (iv) gain on revaluation of contingent consideration, and (v) amortization attributable to intangible assets in connection with acquisitions.

The above items are excluded from net loss because these items are non-cash in nature, or because the amount and timing of these items are unpredictable, are not driven by core results of operations and render comparisons with prior periods and competitors less meaningful. This non-GAAP financial measure is presented for supplemental informational purposes only, should not be considered a substitute for or superior to financial information presented in accordance with GAAP, and may be different from similarly titled non-GAAP financial measures used by other companies. As such, you should consider this non-GAAP financial measure in addition to other financial performance measures presented in accordance with GAAP, including various cash flow metrics, net loss and our other GAAP results.

The following table presents a reconciliation of net loss, the most directly comparable GAAP measure, to Adjusted loss from ordinary activities after tax.


Three Months Ended June 30,


Six Months Ended June 30,


2022


2021


2022


2021


(in thousands)


(in thousands)

Net Loss

$            (32,985)


$              (6,804)


$            (58,207)


$            (10,656)

Add (deduct):








Stock-based compensation

10,429


2,941


16,524


5,140

Form 10 transaction costs

2,138


?


2,138


?

Acquisition and integration costs

1,136


499


10,394


499

Gain on revaluation of contingent consideration

(1,279)


?


(5,279)


?

Amortization attributable to intangible assets in connection with acquisitions

2,178


?


4,254


?

Adjusted loss from ordinary activities after tax

(18,383)


(3,364)


(30,176)


(5,017)

 

Condensed Consolidated Statements of Operations and Comprehensive Loss

(unaudited)

(Dollars in U.S. $, in thousands, except share and per share data)



Three Months Ended June 30,


Six Months Ended June 30,


2022


2021


2022


2021

Subscription revenue

$           36,006


$           19,237


$           69,068


$           36,369

Hardware revenue

6,816


?


16,463


?

Other revenue

6,022


5,772


14,283


11,632

Total revenue

48,844


25,009


99,814


48,001

Cost of subscription revenue

7,903


3,786


14,974


7,520

Cost of hardware revenue

10,773


?


18,579


?

Cost of other revenue

880


974


1,855


1,729

Total cost of revenue

19,556


4,760


35,408


9,249

Gross Profit

29,288


20,249


64,406


38,752

Operating expenses:








Research and development

27,031


12,016


52,768


22,708

Sales and marketing

22,895


10,586


46,137


18,796

General and administrative

12,830


4,454


26,076


7,907

Total operating expenses

62,756


27,056


124,981


49,411

Loss from operations

(33,468)


(6,807)


(60,575)


(10,659)

Other income (expense):








Convertible notes fair value adjustment

532


?


2,107


?

Derivative liability fair value adjustment

415


?


1,328


?

Other income (expense), net

(511)


3


(1,056)


3

Total other income (expense), net

436


3


2,379


3

Loss before income taxes

(33,032)


(6,804)


(58,196)


(10,656)

Provision (benefit) for income taxes

(47)


?


11


?

Net Loss

$          (32,985)


$            (6,804)


$          (58,207)


$          (10,656)

Net loss per share, basic and diluted

$              (0.53)


$              (0.13)


$              (0.95)


$              (0.21)

Weighted-average shares used in computing net loss per share, basic and diluted

61,883,022


50,405,267


61,540,024


50,298,528

Comprehensive loss








Net loss

(32,985)


(6,804)


(58,207)


(10,656)

Change in foreign currency translation adjustment

(14)


?


15


?

Total comprehensive loss

$          (32,999)


$            (6,804)


$          (58,192)


$          (10,656)

 

Condensed Consolidated Balance Sheets

(unaudited)

(Dollars in U.S. $, in thousands, except share and per share data)



June 30,
2022


December 31,
2021

Assets




Current Assets:




Cash and cash equivalents

$       64,264


$     230,990

Accounts receivable, net

19,544


11,772

Costs capitalized to obtain contracts, net

1,582


1,319

Inventory

11,138


2,009

Prepaid expenses and other current assets

11,149


10,590

Total current assets

107,677


256,680

Restricted cash

15,056


355

Property and equipment, net

661


580

Costs capitalized to obtain contracts, net of current portion

196


330

Prepaid expenses and other assets, noncurrent

8,050


3,691

Right-of-use-asset

2,024


1,627

Intangible assets, net

56,822


7,986

Goodwill

133,244


31,127

Total Assets

$     323,730


$     302,376

Liabilities and Stockholders' Equity




Current Liabilities:




Accounts payable

$       11,429


$          3,248

Accrued expenses and other liabilities

29,413


10,547

Escrow liability

13,094


?

Contingent consideration

?


9,500

Convertible notes, current ($3,392 and $4,222 measured at fair value, respectively)

3,392


4,222

Deferred revenue, current

24,835


13,929

Total current liabilities

82,163


41,446

Convertible notes, noncurrent ($6,667 and $8,071 measured at fair value, respectively)

7,089


8,284

Derivative liability, noncurrent

68


1,396

Deferred revenue, noncurrent

3,472


?

Other noncurrent liabilities

1,285


1,205

Total Liabilities

$       94,077


$       52,331

Commitments and Contingencies (Note 11)




Stockholders' Equity




Common Stock, $0.001 par value; 100,000,000 shares authorized as of June 30, 2022
(unaudited) and December 31, 2021; 62,087,105 and 60,221,799 issued and outstanding
as of June 30, 2022 (unaudited) and December 31, 2021, respectively

62


61

Additional paid-in capital

453,437


416,278

Notes due from affiliates

(311)


(951)

Accumulated deficit

(223,550)


(165,343)

Accumulated other comprehensive income

15


?

Total stockholders' equity

229,653


250,045

Total Liabilities and Stockholders' Equity

$     323,730


$     302,376

 

Condensed Consolidated Statements of Cash Flows

(unaudited)

(Dollars in U.S. $, in thousands)



Six months ended


June 30,
2022


June 30,
2021

Cash Flows from Operating Activities:




Net loss

$          (58,207)


$          (10,656)

Adjustments to reconcile net loss to net cash used in operating activities:




Depreciation and amortization

4,502


224

Amortization of costs capitalized to obtain contracts

1,671


2,255

Stock-based compensation expense

16,524


5,140

Compensation expense in connection with revesting notes (Note 7)

(114)


?

Noncash interest (income) expense, net

239


(12)

Convertible notes fair value adjustment

(2,107)


?

Derivative liability fair value adjustment

(1,328)


?

Gain on revaluation of contingent consideration

(5,279)


?

Noncash revenue from affiliate

(511)


?

Changes in operating assets and liabilities:




Accounts receivable, net

20,054


(2,989)

Prepaid expenses and other assets

6,597


3,526

Inventory

(1,605)


?

Costs capitalized to obtain contracts, net

(1,799)


(1,048)

Accounts payable

(15,016)


(1,513)

Accrued expenses and other liabilities

(3,062)


793

Deferred revenue

507


158

Other noncurrent liabilities

406


(797)

Net cash used in operating activities

(38,528)


(4,919)

Cash Flows from Investing Activities:




Cash paid for acquisition, net of cash acquired

(113,401)


?

Internal use software

(396)


?

Cash advance on convertible note receivable

?


(2,500)

Net cash used in investing activities

(113,797)


(2,500)

Cash Flows from Financing Activities:




Proceeds from the exercise of options

1,766


1,288

Taxes paid related to net settlement of equity awards

(1,494)


(1,835)

Issuance of common stock

85


?

Cash paid for deferred offering costs

(705)


?

Proceeds from repayment of notes due from affiliates

648


?

Cash received in advance of the issuance of convertible notes

?


2,110

Net cash provided by financing activities

300


1,563

Net Decrease in Cash, Cash Equivalents, and Restricted Cash

(152,025)


(5,856)

Cash, Cash Equivalents and Restricted Cash at the Beginning of the Period

231,345


56,611

Cash, Cash Equivalents, and Restricted Cash at the End of the Period

$           79,320


$           50,755

Non-cash investing and financing activities:




Fair value of stock issued in connection with an acquisition

$           15,409


$                   ?

Fair value of warrants held as investment in affiliate

5,474


?

Fair value of stock issued in settlement of contingent consideration

4,221


?

Total non-cash investing and financing activities:

$           25,104


$                   ?

 

Note: all references to $ are to US$

SOURCE Life360


These press releases may also interest you

at 20:00
Explorer1 Music Group (EX1) is proud to announce the strategic acquisition of MUSIC BENEFACTORS, an SEC Registered Crowdfunding company, the launch of a new technology and marketing platform, and the...

at 14:39
Vexcel Data Program, the world's largest aerial imagery program, has collected high-resolution aerial imagery of buildings and properties impacted by Hurricane Ian. The unprecedented level of destruction and scope of this...

at 11:00
Yiwu is the world's capital of commodities, Yiwugo.com is the official website of the Yiwu Commodity Market, which is the largest commodity wholesale market in the world. Yiwugo hosts 50,000 merchants and 10 million registered buyers, 10% of whom are...

at 10:38
CGN Europe Energy ("CGN"), a European leader in green energies, is co-organizing the open day of its wind farms located in the south of the city with Town Hall of Assac. Themed "From Wind Farms to Windmills", the 6 kilometers hike is also the first...

at 10:35
Faces & Voices of Recovery is pleased to announce Dr. Rahul Gupta as a guest speaker at the annual Recovery Leadership Summit, held this year in St. Paul, MN from October 2-5. Rahul Gupta, MD, MPH, MBA, FACP, is the first medical doctor to serve as...

at 10:01
The Janssen Pharmaceutical Companies of Johnson & Johnson...



News published on 15 august 2022 at 19:14 and distributed by: